Build vs buy AI agents: a decision framework for Australian businesses
Build vs buy AI agents comes down to three questions: is the workflow generic, who owns the risk when the agent is wrong, and who maintains it in year three. The commissioning option sits between the two, and most Australian businesses should sequence all three.
Build when the agent embodies a process that differentiates your business and your engineers will need to keep changing it. Buy when the job is generic and a vendor's roadmap will do the maintenance. Commission a purpose-built agent when the process is specific to your organisation, the data is sensitive, and nobody on your team has the specialised skills to own it alone.
Most Australian businesses facing this decision should not pick one of the three. They should sequence them: buy the boring parts, build or commission the parts that touch your customers, and know which is which before anyone signs anything.
Most agentic AI projects right now are early stage experiments or proof of concepts that are mostly driven by hype and are often misapplied.
Why the build vs buy decision keeps getting harder
The build vs buy question has passed the point where deferring is a strategy. Analyst tracking puts support-agent use cases at 57% enterprise adoption and climbing, with data analysis at 44% and code generation at 40% not far behind.
Gartner places agent development platforms at the peak of inflated expectations, with two to five years before the useful survivors reach mainstream. The same firm predicts that by 2027, 40% of agentic AI projects will be cancelled, killed by escalating costs, unclear business value, or inadequate risk controls.
Read those two facts together and they describe the decision you are making. The technology works often enough that doing nothing looks negligent. The tooling market is churning hard enough that picking the wrong platform this year is a reasonable outcome, and picking it expensively is not. The failure mode is choosing before you know which parts of your problem are generic and which are yours alone.
The question underneath the question
"Build vs buy" sounds like one question. It is usually three, and businesses that conflate them buy the wrong thing or build the wrong thing.
First: is the workflow generic or specific? An agent that answers "where is my order" from your order system is doing a job a thousand other businesses have. An agent that triages clinical calls against your triage policy, your escalation rules, and your state's health directives is not. Generic workflows have vendors. Specific workflows have you.
Second: who owns the risk when it is wrong? Every agent is wrong sometimes. The question is what "wrong" costs and who wears it. A support agent that hallucinates a shipping date costs an apology. A patient-intake agent that misroutes a clinical priority costs more than an apology, and a regulator may ask questions. The higher the stakes, the more the ownership question dominates the cost question.
Third: who maintains it in year three? Agents are not projects that end. Models change, your product changes, the vendor's pricing changes, the regulations change. Build puts that maintenance on your team permanently. Buy outsources it to a vendor whose incentives and roadmap you do not control. Commissioning sits between them, and the contract terms decide which side of the line it lands on.
When buying an AI agent is the right call
Buying is the right call when all three of these hold: the workflow is generic enough that a vendor's product covers it without heavy customisation; the data flowing through the agent is not a competitive asset and carries no unusual regulatory handling requirements; and your team has no reason to build agent capability as a lasting skill.
The case for buying is speed and maintenance. A vendor has already solved the boring 80%: authentication, rate limiting, conversation management, analytics, model upgrades. Building those from scratch teaches your team things nobody is paying you to learn.
Where buying goes wrong is the demo. Platform demos are built to make the generic case look like yours. Before you sign, run the demo against your real data, your real edge cases, and the real volume. A pilot that stalls after the demo is one of the most common patterns in this market, and it is almost always a platform that fit the demo and not the operation.
When to build the agent in-house
Build when the agent is the product, or close to it. The workflow encodes a process advantage your competitors do not have, and you want to keep it that way. The agent needs deep integration with systems a vendor will never see, or data governance rules a multi-tenant platform cannot satisfy. And you have, or can hire, engineers who will own it for years, not months.
The case against building is opportunity cost. Every senior engineer month spent rebuilding conversation management is a month not spent on the thing that differentiates your business. Teams that build successfully usually build a thin, well-instrumented agent on top of bought infrastructure, not an agent platform from first principles.
Commissioning: the option between build and buy
Between "build it ourselves" and "buy a platform" sits a third path that suits most organisations reading this: commission an agent built for your organisation, from a delivery partner, on infrastructure you own.
The distinction matters more than the label. A commissioned agent is software built against your workflow, your data, and your risk posture. The build partner brings the specialised skills: evaluation harnesses, guardrails, model integration, the unglamorous plumbing that decides whether an agent is reliable. Your team keeps ownership of the logic and the data.
Commissioning fits when the workflow is specific and your team cannot carry the specialised build alone. It is the common shape in regulated industries: health, insurance, government. The buyer keeps the audit trail, the data stays inside the boundary the regulator cares about, and the partner makes the maintenance handover real.
What an AI agent costs: four drivers to price
Real numbers on agent delivery costs are unpublished in the Australian market, which is why most first budgets are wrong. Without quoting figures we cannot stand behind, the cost drivers are knowable in advance, and they are the same whether you build or buy.
Integration depth: the agent is cheap; the connections to your CRM, your scheduling system, your knowledge base are where the work lives. An agent that needs five system integrations is not twice the work of one that needs two.
Evaluation and guardrails: testing whether an agent is safe to put in front of customers is a real engineering discipline. Budgets that skip it pay for it in production incidents.
Volume and peak behaviour: an agent that handles Tuesday-afternoon traffic and an agent that survives a Monday-morning surge are different products.
Change: every model upgrade, every product change, every regulation change lands as maintenance. Whoever maintains it, this line item never reaches zero.
Ask any vendor, partner, or internal team to price against these four drivers before they price against "an AI agent". The quotes you get back will be comparable, and the assumptions visible.
A sequence that works
For most organisations we talk to, the workable sequence is this. Map the workflow before the tooling: write down what the process is today, including the exceptions. The exceptions are the project.
Buy the generic layer. Model access, conversation infrastructure, observability. Nobody should build these in 2026.
Pilot on one workflow with a real success measure. Not "engagement". A number: calls deflected, appointments booked, claims triaged, hours returned to staff.
Decide build vs commission per workflow, not per company. The answer will differ across your operations, and it should.
Plan the maintenance before the launch. Name who owns the agent in year two. If nobody does, you have a demo.
Where Airteam sits in this
We build purpose-built AI agents for Australian organisations, which means we have a point of view about when you should not hire us. If a platform covers your workflow, buy the platform; we will tell you so in discovery. Where we work is the specific, regulated, integrated middle: agents for health services, insurers, and government, built on infrastructure you own, with the delivery model in the open.
Our work with healthdirect on a voice triage prototype and with private health insurers on claims and member services is the evidence. Our security posture (AWS Advanced Tier partner, ISO 27001 certified) is the baseline, not the pitch.
If you are working through this decision now, a scoped discovery with us is a fixed-size engagement. We map the workflow, price the four cost drivers above against your real systems, and give you a recommendation you could take to another builder. Ask us for one.